Skip to content

Dr reddy stock price target

Dr reddy stock price target

Dr. Reddy's Laboratories Announces First-to-Market Launch Of Naloxone Hydrochloride Injection USP, 2 Mg/2 ML (1 Mg/mL) Single-dose Prefilled Syringe In The U.S. Market States Target Mylan Dr. Reddy's Laboratories Ltd. ADR Stock- 37.0 Dr. Reddy's Laboratories Ltd. ADR Change: 3.35%, current price: 37.0 € This page uses Cookies. For proper functioning of the page Cookies are needed. DR REDDYS LABS (DRREDDY.NS) stock price ... - Yahoo Finance UK Dr. Reddy’s Laboratories Ltd. (along with its subsidiaries together referred to as "Dr. Reddy’s") announced today that it is voluntarily recalling four lots (ACB902, ACB903, ACB904, ACB905) of Phytonadione Injectable Emulsion USP, 10 mg/mL, Single-Dose Ampules to the hospital level. DRRD:Natl India Stock Quote - Dr Reddy's Laboratories Ltd ...

Dr. Reddy's Laboratories Ltd. Share Price Target and Information. Get complete details on Dr. Reddy's Laboratories Ltd. share price data, company profile data, 

Find the latest Dr. Reddy's Laboratories Ltd (RDY) stock quote, history, news and other vital information to help you with your stock trading and investing. Dr. Reddy's Laboratories Ltd Common Stock (RDY) Analyst ... Dr. Reddy's Laboratories Ltd Common Stock (RDY) Analyst Research. RDY Analyst Ratings. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. RDY Stock Price, Forecast & News (Dr.Reddy's Laboratories)

Dr. Reddy's Laboratories Ltd. ADR Change: 3.35%, current price: 37.0 € This page uses Cookies. For proper functioning of the page Cookies are needed.

Dr ReddyS Laboratories Analysts: This is the Analysts-site for the company Dr ReddyS Laboratories on Markets Insider Stock Analysis of Dr Reddys Laboratories ,Strength, Birds ... Stock has jumped by more than 10% in last two weeks from its lowest level of 2495.05 dt 19-Mar-20: Stock has jumped by more than 15% in last One Month from its lowest level of 2495.05 dt 19-Mar-20.: Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading. Bearish harami Candlestick pattern was formed by Dr. Reddy's Laboratories Ltd. on Stock Tips, Intraday Stock Tips Dr. Reddys Laboratories ... Stock Tips - Free Intraday Stock Market Tips of Dr. Reddys Laboratories Limited Current DRREDDY Stock Price & Stock Information ‣ Best time to take position: After 10.30 am morning. Updated on 20th Feb 2020 Evening after Share Market - only valid for Intraday Shares & Stocks Trading

Stock has jumped by more than 10% in last two weeks from its lowest level of 2495.05 dt 19-Mar-20: Stock has jumped by more than 15% in last One Month from its lowest level of 2495.05 dt 19-Mar-20.: Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading. Bearish harami Candlestick pattern was formed by Dr. Reddy's Laboratories Ltd. on

RDY | Dr. Reddy's Laboratories Ltd. ADR Overview | MarketWatch Dr. Reddy's Laboratories Ltd. ADR. Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics 2020 Dr Reddy (DRREDDY) technical analysis [forecast ... Volume Weighted Averaged Price (VWAP) for short term is 2909.06 and Dr Reddy DRREDDY stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards. People seem to be coming out and selling the Dr Reddy DRREDDY stock. Volume based technical analysis of Dr Reddy DRREDDY stock is negative.

Dr. Reddy's Laboratories Ltd Common Stock (RDY) Analyst Research. RDY Analyst Ratings. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.

Stock Tips, Intraday Stock Tips Dr. Reddys Laboratories Limited daily updated, Current DRREDDY Stock Price & Stock Information Stock Target 1; 3723 Get the latest Dr ReddyS Laboratories stock price and detailed information including news, historical charts and realtime prices. YTD % Chg 27.59. 1 Year % Chg 33.32. Market Cap -. Shares Outstanding -. Beta -. Dividend (Yield) 20 (0.54%). Div Amount 20.00. Ex Div Date 2019-07-15. Dr. Reddy's Laboratories Ltd (NYSE: RDY) stock research, profile, news, analyst Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of  4 Nov 2019 Analysts were mixed on Dr Reddy's Laboratories despite the company reporting a two-fold jump in net profit on Friday. However, the stock, on  In depth view into RDY (Dr Reddy's Laboratories) stock including the latest price, news, dividend history, earnings information and financials.

Apex Business WordPress Theme | Designed by Crafthemes